Reviewing the global burden of acne: how could we improve care to reduce the burden?*
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Acne (also known as acne vulgaris) remains the most common inflammatory dermatosis treated worldwide, as estimated by global skin disease prevalence studies. Latest reports suggest that the prevalence may be increasing in adolescents and adults, particularly female adults. The concept of 'burden of skin disease' is multidimensional and can be difficult to quantify in light of different healthcare systems across the globe. In acne, the resulting burden may vary according to patient demographics, access to treatments and duration of the disease. The visible nature of acne, symptoms and sequelae all contribute physically and psychosocially to the overall burden of disease, as do the costs required for management. Acne typically presents in adolescence at a time of significant transition. Profound effects on functional status have been demonstrated, along with a strong impact on interpersonal relationships, social functioning and mental health. The high prevalence of acne also presents an economic burden for society. The widespread and prolonged use of antibiotics introduces a potential added burden through resulting antimicrobial resistance. A James Lind Alliance Acne Priority Setting Partnership has identified numerous areas to inform future research, which would help to improve acne management and reduce the burden. The lack of standardized assessments is a major issue in acne trials and challenges the ability to compare treatments and perform meta-analyses. This paper reviews the current literature on burden of acne, identifies areas of treatment uncertainties and summarizes the work of the Acne Core Outcome Research Network as a means of supporting a reduction in the burden of disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Hay, R. J., Johns, N. E., Williams, H. C., Bolliger, I. W., Dellavalle, R. P., Margolis, D. J., Marks, R., Naldi, L., Weinstock, M. A., Wulf, S. K., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.446 · Cited by 1,706
Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study 2013
Karimkhani, C., Dellavalle, R. P., Coffeng, L. E., Flohr, C., Hay, R. J., Langan, S. M., Nsoesie, E. O., Ferrari, A. J., Erskine, H. E., Silverberg, J. I., et al. (2017) · JAMA Dermatology · doi:10.1001/jamadermatol.2016.5538 · Cited by 742
Bickers (2006) · doi:10.1016/j.jaad.2006.05.048 · Cited by 741
Global Burden of Skin Disease: Inequities and Innovations
Seth, D., Cheldize, K., Brown, D., & Freeman, E. E. (2017) · Current Dermatology Reports · doi:10.1007/s13671-017-0192-7 · Cited by 366
Sundstrom, A., Alfredsson, L., Sjolin-Forsberg, G., Gerden, B., Bergman, U., & Jokinen, J. (2010) · BMJ · doi:10.1136/bmj.c5812 · Cited by 184
McCabe, R. E., Antony, M. M., Summerfeldt, L. J., Liss, A., & Swinson, R. P. (2003) · Cognitive Behaviour Therapy · doi:10.1080/16506070310005051 · Cited by 182
Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review
Layton, A. M., Eady, E. A., Whitehouse, H., Del Rosso, J. Q., Fedorowicz, Z., & van Zuuren, E. J. (2017) · American Journal of Clinical Dermatology · doi:10.1007/s40257-016-0245-x · Cited by 126
Self-citationFrequency and characteristics of acne‐related post‐inflammatory hyperpigmentation
Abad‐Casintahan, F., Chow, S. K. W., Goh, C. L., Kubba, R., Hayashi, N., Noppakun, N., See, J., Suh, D. H., Xiang, L. H. F., Kang, S., et al. (2016) · The Journal of Dermatology · doi:10.1111/1346-8138.13263 · Cited by 94
Quality of life issues for South Africans with acne vulgaris
Mosam, A., Vawda, N. B., Gordhan, A. H., Nkwanyana, N., & Aboobaker, J. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2004.01678.x · Cited by 57
Cited by
Management of Acne Vulgaris: A Review
Eichenfield, D. Z., Sprague, J., & Eichenfield, L. F. (2021) · JAMA · doi:10.1001/jama.2021.17633 · Cited by 389
Del Rosso, J. Q., & Kircik, L. (2024) · Journal of Dermatological Treatment · doi:10.1080/09546634.2023.2296855 · Cited by 68
Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data
Paljarvi, T., McPherson, T., Luciano, S., Herttua, K., & Fazel, S. (2022) · British Journal of Dermatology · doi:10.1111/bjd.21049 · Cited by 31
Tjiu, J.-W., & Lu, C.-F. (2025) · Medicina · doi:10.3390/medicina61122152 · Cited by 10
Yang, X., Ruan, D., Ye, F., Qiu, X., Li, S., Huang, L., Zouboulis, C. C., Mo, X., Jiang, X., & Ju, Q. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04221-8 · Cited by 4
Metadata
- Authors
- Layton, A. M., Thiboutot, D., & Tan, J.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-09-24
- Volume
- 184
- Issue
- 2
- Pages
- 219-225
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W3048196286
- Cited by
- 172
- References
- 10
- FWCI
- 10.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reviewing the global burden of acne: how could we improve care to reduce the burden?*. https://app.cochat.ai/papers/10.1111/bjd.19477
- The paper
- Layton, A. M., Thiboutot, D., & Tan, J. (2021). Reviewing the global burden of acne: how could we improve care to reduce the burden?*. British Journal of Dermatology. https://doi.org/10.1111/bjd.19477
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.